Skin cancer patients to trial cancer vaccine

Patients with advanced skin cancer in England are set to access trials of a new cancer vaccine. The needle-free injection, which is given for up to two years, works by boosting the immune system’s response and helping it recognise, attack and remember cancer cells, to help stop the disease returning. The NHS has partnered with UK life-sciences company Scancell to widen access for patients at hospitals across the country, with seven sites initially registered and more to follow, and the first patients expected to be referred in May.

Keep up to date

Sign up to receive our daily news alerts straight to your inbox. Subscribe to our weekly newsletter containing a summary of the week’s news, blog and vote on our poll.

Weekly Newsletter

Daily news updates

Have a discussion

Help keep the conversation going between meetings by creating a forum to hold discussions with your members. It’s an easy way to manage and communicate with members.

Create a network

Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.

Networks can be open to all or available only to a closed group defined by the administrator.

Join or create a network here.